Matches in Nanopublications for { ?s ?p "[New drugs that inhibit tyrosine kinase receptors (TKRs) are being investigated for treatment and this study was undertaken to determine the expression and mutational state for 3 TKRs (c-kit, platelet-derived growth factor receptor [PDGFR] alpha, and PDGFR beta) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP614132.RAUONhuSv5hCsj25GmnLkJwGVGv2Z7dFzkS7QSLoMH-q4130_assertion description "[New drugs that inhibit tyrosine kinase receptors (TKRs) are being investigated for treatment and this study was undertaken to determine the expression and mutational state for 3 TKRs (c-kit, platelet-derived growth factor receptor [PDGFR] alpha, and PDGFR beta) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614132.RAUONhuSv5hCsj25GmnLkJwGVGv2Z7dFzkS7QSLoMH-q4130_provenance.
- NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_assertion description "[New drugs that inhibit tyrosine kinase receptors (TKRs) are being investigated for treatment and this study was undertaken to determine the expression and mutational state for 3 TKRs (c-kit, platelet-derived growth factor receptor [PDGFR] alpha, and PDGFR beta) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487265.RASXbyrLjTPBr5oRo5-Vz3ZC9TzNE416UxbCd4CDnh7Os130_provenance.
- NP487266.RAJHpxHBeugDoPnLTDD9-4DugAtQwT9PGvN3ASAXOmgl8130_assertion description "[New drugs that inhibit tyrosine kinase receptors (TKRs) are being investigated for treatment and this study was undertaken to determine the expression and mutational state for 3 TKRs (c-kit, platelet-derived growth factor receptor [PDGFR] alpha, and PDGFR beta) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP487266.RAJHpxHBeugDoPnLTDD9-4DugAtQwT9PGvN3ASAXOmgl8130_provenance.
- NP614246.RAtdr_TyvzyXpVIAPnKd7d115nKP1787qsfrg8Ox0DvoI130_assertion description "[New drugs that inhibit tyrosine kinase receptors (TKRs) are being investigated for treatment and this study was undertaken to determine the expression and mutational state for 3 TKRs (c-kit, platelet-derived growth factor receptor [PDGFR] alpha, and PDGFR beta) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614246.RAtdr_TyvzyXpVIAPnKd7d115nKP1787qsfrg8Ox0DvoI130_provenance.